Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +116.5% | -544.8% | 2 / 3 | +521.6% | +5.39 pp | -481.02 pp | -3.5% | 0.06 | — | 1,7 | +521,6% | 0,3 | +116,5% | — | 156.09 | — |
| Pts | 12 | 0 | 8 | 12 | 12 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 4.200 (close price on 2026-10-16)EPS (TTM): −22,2
Financial charts
1.Revenue & growth
VND bn1,73Q2/26
1.Revenue & growth
VND bn1,73Q2/26
2.Profit & growth
VND bn0,34Q2/26
3.Profit mix (Penman)
VND bn-2,19Q2/26
4.Margins & cost structure
%-0.1%Q2/26
5.Returns & cash cycle
% · days-3.8%Q2/26
6.Earnings quality & cash
VND bn-2,10Q2/26
7.Asset structure
VND bn76,5Q2/26
8.Funding & debt health
VND bn · times76,5Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %-8,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %56Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-8170%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26